Evidence map›Paper›PMID 35650194›Full record

ArticleNature communications2022

Mechanical forces couple bone matrix mineralization with inhibition of angiogenesis to limit adolescent bone growth.

Maria Dzamukova, Tobias M Brunner, Jadwiga Miotla-Zarebska, Frederik Heinrich, Laura Brylka, Mir-Farzin Mashreghi, Anjali Kusumbe, Ralf Kühn, Thorsten Schinke, Tonia L Vincent and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Maria DzamukovaPitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Centre (DRFZ), a Leibniz Institute, Berlin, Germany. maria.dzamukova@drfz.de.ORCID 0000-0002-2389-3222
Tobias M BrunnerPitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Centre (DRFZ), a Leibniz Institute, Berlin, Germany.
Jadwiga Miotla-ZarebskaCentre for Osteoarthritis Pathogenesis Versus Arthritis, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Frederik HeinrichTherapeutic Gene Regulation, Regine von Ramin Lab Molecular Rheumatology, German Rheumatism Research Centre (DRFZ), a Leibniz Institute, Berlin, Germany.ORCID 0000-0001-6097-5422
Laura BrylkaDepartment of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-4734-9966
Mir-Farzin MashreghiTherapeutic Gene Regulation, Regine von Ramin Lab Molecular Rheumatology, German Rheumatism Research Centre (DRFZ), a Leibniz Institute, Berlin, Germany.ORCID 0000-0002-8015-6907
Anjali KusumbeTissue and Tumour Microenvironments Group, University of Oxford, Oxford, UK.ORCID 0000-0002-1911-5495
Ralf KühnMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.ORCID 0000-0003-1694-9803
Thorsten SchinkeDepartment of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-8576-0177
Tonia L VincentCentre for Osteoarthritis Pathogenesis Versus Arthritis, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Max LöhningPitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Centre (DRFZ), a Leibniz Institute, Berlin, Germany. max.loehning@charite.de.ORCID 0000-0001-6382-7281
Humboldt-Universität zu Berlin · DEUniversity of Oxford · GBGerman Rheumatism Research Centre · DEUniversität Hamburg · DEMax Delbrück Center · DE

Funding

Cancer Research UK 30309Medical Research Council MR/P02209X/1Versus Arthritis 21621
6 · The paper itself

Abstract

Bone growth requires a specialised, highly angiogenic blood vessel subtype, so-called type H vessels, which pave the way for osteoblasts surrounding these vessels. At the end of adolescence, type H vessels differentiate into quiescent type L endothelium lacking the capacity to promote bone growth. Until now, the signals that switch off type H vessel identity and thus limit adolescent bone growth have remained ill defined. Here we show that mechanical forces, associated with increased body weight at the end of adolescence, trigger the mechanoreceptor PIEZO1 and thereby mediate enhanced production of the kinase FAM20C in osteoblasts. FAM20C, the major kinase of the secreted phosphoproteome, phosphorylates dentin matrix protein 1, previously identified as a key factor in bone mineralization. Thereupon, dentin matrix protein 1 is secreted from osteoblasts in a burst-like manner. Extracellular dentin matrix protein 1 inhibits vascular endothelial growth factor signalling by preventing phosphorylation of vascular endothelial growth factor receptor 2. Hence, secreted dentin matrix protein 1 transforms type H vessels into type L to limit bone growth activity and enhance bone mineralization. The discovered mechanism may suggest new options for the treatment of diseases characterised by aberrant activity of bone and vessels such as osteoarthritis, osteoporosis and osteosarcoma.

Indexed as

Calcification, PhysiologicNeovascularization, PhysiologicStress, MechanicalAdolescentBone DevelopmentBone MatrixExtracellular Matrix ProteinsHumansIon ChannelsMorphogenesisPhosphoproteinsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2DMP1 protein, humanExtracellular Matrix ProteinsIon ChannelsKDR protein, humanPhosphoproteinsPIEZO1 protein, humanVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID35650194
PMCPMC9160028
OpenAlexW4281728212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.